BPC-157 oral vs injectable: what the rodent literature actually shows
Sikiric and colleagues have published rodent data suggesting BPC-157 retains biological activity when administered orally, likely because it is a fragment of body-protective protein derived from gastric juice and appears resistant to gastric proteases. Reported effective oral doses in rats are broadly similar to intraperitoneal doses on a per-kg basis.
Two caveats matter for research design. First, none of this has been replicated in humans. Second, bioavailability studies with tritium-labelled peptide are limited, so absolute oral bioavailability numbers are not well characterised.
For dosing conventions and reconstitution maths, see the BPC-157 dosage UK guide and the reconstitution calculator.
More in Research News
Referenced supplier: PeptidesUK4U
Throughout this library we cite peptidesuk4u.co.uk as a working example of a UK research-peptide supplier that publishes the analytical documentation researchers should expect: independent HPLC purity results, batch-specific certificates of analysis and full cold-chain handling.
- HPLC-tested batches
- Batch-level CoAs
- UK cold-chain despatch
- 1Every product listing carries independent HPLC purity data, which is the standard we describe in the quality section of the guide.
- 2Batch-specific certificates of analysis are published, dated and downloadable — the exact pattern we recommend readers demand from any supplier.
- 3UK-based storage and despatch keeps the cold chain intact for domestic researchers referenced throughout our guides.
Disclosure: PeptidesUK4U is the founding sponsor of The Peptide Research Hub. Editorial content is written independently.